Filing Details

Accession Number:
0000899243-17-004754
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-02-21 16:32:54
Reporting Period:
2017-02-17
Filing Date:
2017-02-21
Accepted Time:
2017-02-21 16:32:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1341235 Aldeyra Therapeutics Inc. ALDX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1579179 C Todd Brady C/O Aldeyra Therapeutics, Inc.
131 Hartwell Avenue
Lexington MA 02421
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-02-17 22,223 $4.50 64,408 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Represents shares of common stock purchased by the Reporting Person in the Issuer's follow-on offering, which closed on February 17, 2017.